President and CEO Mike Carrel outlined the company’s strategy and growth outlook during a presentation and Q&A at a JPMorgan ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...
Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...
Atricure’s overall stock score is driven by strong financial performance and positive technical indicators. The earnings call highlighted significant growth and raised guidance, contributing to a high ...
A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...
Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.
6d
Field Medical, Inc.: Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...
Boston Scientific Corp.'s Farapoint, its latest pulsed field ablation catheter, received U.S. FDA approval for use as an adjunctive device when treating persistent atrial fibrillation that requires ...
Johns Hopkins biomedical engineers Ishan Vatsaraj, Stanley Chun Ming Wu, and Jaemyung Shin have been awarded highly ...
AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial ...
“Having access to high-quality intracardiac imaging without the constraints of traditional capital equipment is compelling,” added Dr. Zahr. “This new platform has the potential to broaden access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback